现有研究局限阻碍肿瘤消融与肾部分切除术治疗局限性肾肿块的可靠比较:欧洲泌尿外科学会肾细胞癌指南小组系统综述
欧洲泌尿外科学会肾细胞癌指南小组开展了一项方案导向的系统综述,比较热消融与肾部分切除术治疗T1N0M0肾肿块的效果。现有数据不足以就热消融的临床有效性得出强而明确的结论,热消融可谨慎考虑为肾部分切除术的替代方案,但需告知患者存在不确定性。
要点
- 所有纳入研究偏倚风险高或不确定,证据质量低。
- 热消融安全性数据有限,长期肿瘤学效果相比肾部分切除术仍不确定。
- 热消融可谨慎作为T1N0M0肾肿块的替代方案,但需充分告知不确定性。
核心结论
- 当前数据不足以就热消融治疗T1N0M0肾肿块的临床有效性相比肾部分切除术做出强而明确的结论。
- 热消融可谨慎考虑为T1N0M0肾肿块的肾部分切除术替代方案,但患者必须被告知普遍存在的不确定性。
研究设计与样本
- 欧洲泌尿外科学会肾细胞癌指南小组进行的方案导向系统综述,遵循PRISMA指南。
主要发现
- 所有纳入研究的偏倚风险评估为高或不确定,绝大多数为回顾性观察性研究,对照匹配差且随访短。
- 有限数据显示热消融是安全的,但其长期肿瘤学效果相比肾部分切除术仍不确定。
- 对11项已有系统综述的质量评估(AMSTAR)显示所有综述置信评级低,除两项外均评为极低。
临床怎么用
- 热消融可谨慎考虑为T1N0M0肾肿块患者肾部分切除术的替代方案。
- 决策时应向患者充分告知热消融相比肾部分切除术在长期肿瘤学效果上的不确定性。
局限性
- 所有纳入研究偏倚风险高或不确定,多为回顾性观察性研究,对照匹配差且随访短。
- 已有系统综述质量评估均为低或极低置信评级。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
The European Association of Urology (EAU) Renal Cell Carcinoma (RCC) Guideline Panel performed a protocol-driven systematic review (SR) on thermal ablation (TA) compared with partial nephrectomy (PN) for T1N0M0 renal masses, in order to provide evidence to support its recommendations. The Preferred Reporting Items for Systematic Reviews and Meta-analyses (PRISMA) guidelines were followed, and only comparative studies published between 2000 and 2019 were included. Twenty-six nonrandomised comparative studies were included, recruiting a total of 167 80 patients. Risk of bias (RoB) assessment revealed high or uncertain RoB across all studies, with the vast majority being retrospective, observational studies with poorly matched controls and short follow-up. Limited data showed TA to be safe, but its long-term oncological effectiveness compared with PN remains uncertain. A quality assessment of pre-existing SRs (n=11) on the topic, using AMSTAR, revealed that all SRs had low confidence rating, with all but two SRs being rated critically low. In conclusion, the current data are inadequate to make any strong and clear conclusions regarding the clinical effectiveness of TA for treating T1N0M0 renal masses compared with PN. Therefore, TA may be cautiously considered an alternative to PN for T1N0M0 renal masses, but patients must be counselled carefully regarding the prevailing uncertainties. We recommend specific steps to improve the evidence base based on robust primary and secondary studies. PATIENT SUMMARY: In this report, we looked at the literature to determine the effectiveness of thermoablation (TA) in the treatment of small kidney tumours compared with surgical removal. We found that TA could cautiously be offered as an option due to many remaining uncertainties regarding its effectiveness.
引用
- Abu-Ghanem Y, Fernández-Pello S, Bex A, et al. Limitations of Available Studies Prevent Reliable Comparison Between Tumour Ablation and Partial Nephrectomy for Patients with Localised Renal Masses: A Systematic Review from the European Association of Urology Renal Cell Cancer Guideline Panel. Eur Urol Oncol. 2020. PMID: 32245655. doi:10.1016/j.euo.2020.02.001
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。